Cargando…
Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
An expert group of 40 pain specialists from 16 countries performed a first assessment of the value of predictors for treatment success with 5% lidocaine-medicated plaster in the management of cancer pain with neuropathic components and trigeminal neuropathic pain. Results were based on the retrospec...
Autores principales: | Kern, Kai-Uwe, Nalamachu, Srinivas, Brasseur, Louis, Zakrzewska, Joanna M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623573/ https://www.ncbi.nlm.nih.gov/pubmed/23630431 http://dx.doi.org/10.2147/JPR.S39957 |
Ejemplares similares
-
Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma
por: Nicolaou, Andrew, et al.
Publicado: (2011) -
Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster
por: Likar, Rudolf, et al.
Publicado: (2012) -
Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster
por: Correa-Illanes, Gerardo, et al.
Publicado: (2010) -
Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves
por: Correa-Illanes, Gerardo, et al.
Publicado: (2012) -
Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series
por: Casale, Roberto, et al.
Publicado: (2014)